21.01.2015 Views

2014 Oryzon Genomics S.A. Product Pipeline Review Market,Size,Share

Big Market Research, Oryzon Genomics S.A. Market Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014. Visit for complete report @ http://www.bigmarketresearch.com/oryzon-genomics-sa-product-pipeline-review-2014-market Global Markets Direct’s, ‘Oryzon Genomics S.A. - Product Pipeline Review - 2014’, provides an overview of the Oryzon Genomics S.A.’s pharmaceutical research and development focus.

Big Market Research, Oryzon Genomics S.A. Market Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014. Visit for complete report @ http://www.bigmarketresearch.com/oryzon-genomics-sa-product-pipeline-review-2014-market
Global Markets Direct’s, ‘Oryzon Genomics S.A. - Product Pipeline Review - 2014’, provides an overview of the Oryzon Genomics S.A.’s pharmaceutical research and development focus.

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Oryzon</strong> <strong>Genomics</strong><br />

S.A. - <strong>Product</strong><br />

<strong>Pipeline</strong> <strong>Review</strong> -<br />

<strong>2014</strong><br />

www.bigmarketresearch.com


Report Description<br />

Acquired (Autoimmune) Hemolytic Anemia<br />

Summary<br />

Global <strong>Market</strong>s Direct’s, ‘<strong>Oryzon</strong> <strong>Genomics</strong> S.A. - <strong>Product</strong> <strong>Pipeline</strong> <strong>Review</strong> - <strong>2014</strong>’,<br />

provides an overview of the <strong>Oryzon</strong> <strong>Genomics</strong> S.A.’s pharmaceutical research and<br />

development focus.<br />

This report provides comprehensive information on the current therapeutic<br />

developmental pipeline of <strong>Oryzon</strong> <strong>Genomics</strong> S.A.’s, complete with comparative analysis at<br />

various stages, therapeutics assessment by drug target, mechanism of action (MoA),<br />

route of administration (RoA) and molecule type. It also reviews latest updates, and<br />

featured news and press releases, along with special features on late-stage and<br />

discontinued projects.<br />

Get More Details At: http://www.bigmarketresearch.com/oryzon-genomics-sa-productpipeline-review-<strong>2014</strong>-market


Report Description<br />

Global <strong>Market</strong>s Direct’s report features investigational drugs from across globe covering<br />

over 20 therapy areas and nearly 3,000 indications. The report is built using data and<br />

information sourced from Global <strong>Market</strong>s Direct’s proprietary databases,<br />

Company/University websites, SEC filings, investor presentations and featured press<br />

releases from company/university sites and industry-specific third party sources, put<br />

together by Global <strong>Market</strong>s Direct’s team. Drug profiles/records featured in the report<br />

undergoes periodic updation following a stringent set of processes that ensures that all<br />

the profiles are updated with the latest set of information. Additionally, processes<br />

including live news & deals tracking, browser based alert-box and clinical trials registries<br />

tracking ensure that the most recent developments are captured on a real time basis.<br />

The report enhances decision making capabilities and help to create effective counter<br />

strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new<br />

targets and MOAs to produce first-in-class and best-in-class products.<br />

Note*: Certain sections in the report may be removed or altered based on the availability<br />

and relevance of data for the indicated disease.


Report Description<br />

Scope<br />

- The report provides brief overview of <strong>Oryzon</strong> <strong>Genomics</strong> S.A. including business<br />

description, key information and facts, and its locations and subsidiaries<br />

- The report reviews current pipeline of <strong>Oryzon</strong> <strong>Genomics</strong> S.A.’s human therapeutic<br />

division and enlists all their major and minor projects<br />

- The report features product description and descriptive mechanism of action for key<br />

pipeline products along with the product’s developmental history and major milestones<br />

- Special feature on out-licensed and partnered product portfolio<br />

- The report summarizes all the dormant and discontinued pipeline projects<br />

- Latest company statement<br />

- Latest news and deals relating to the <strong>Oryzon</strong> <strong>Genomics</strong> S.A.’s pipeline products<br />

Enquire about report - http://www.bigmarketresearch.com/report-enquiry/152192


Report Description<br />

Reasons to buy<br />

- Evaluate <strong>Oryzon</strong> <strong>Genomics</strong> S.A.’s strategic position with total access to detailed<br />

information on its product pipeline<br />

- Assess the growth potential of <strong>Oryzon</strong> <strong>Genomics</strong> S.A. in its therapy areas of focus<br />

- Identify new drug targets and therapeutic classes in the <strong>Oryzon</strong> <strong>Genomics</strong> S.A.’s R&D<br />

portfolio and develop key strategic initiatives to reinforce pipeline in those areas<br />

- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio<br />

gaps<br />

- Develop strategic initiatives by understanding the focus areas of <strong>Oryzon</strong> <strong>Genomics</strong> S.A.<br />

and exploit collaboration and partnership opportunities


Report Description<br />

Reasons to buy<br />

- Identify emerging players with potentially strong product portfolio and create effective<br />

counter-strategies to gain competitive advantage<br />

- Plan mergers and acquisitions effectively by identifying the most promising pipeline of<br />

<strong>Oryzon</strong> <strong>Genomics</strong> S.A.<br />

- Develop and design in-licensing and out-licensing strategies by identifying prospective<br />

partners with the most attractive projects to enhance and expand business potential and<br />

scope<br />

- Explore the dormant and discontinued projects of <strong>Oryzon</strong> <strong>Genomics</strong> S.A. and identify<br />

potential opportunities in those areas<br />

- Avoid Intellectual Property Rights related issues


Table Of Content<br />

• List of Tables<br />

• List of Figures<br />

• <strong>Oryzon</strong> <strong>Genomics</strong> S.A. Snapshot<br />

• <strong>Oryzon</strong> <strong>Genomics</strong> S.A. Overview<br />

• Key Information<br />

• Key Facts<br />

• <strong>Oryzon</strong> <strong>Genomics</strong> S.A. - Research and Development Overview<br />

• Key Therapeutic Areas<br />

• <strong>Oryzon</strong> <strong>Genomics</strong> S.A. - <strong>Pipeline</strong> <strong>Review</strong><br />

• <strong>Pipeline</strong> <strong>Product</strong>s by Stage of Development<br />

• <strong>Pipeline</strong> <strong>Product</strong>s - Monotherapy<br />

• <strong>Pipeline</strong> <strong>Product</strong>s - Out-Licensed <strong>Product</strong>s<br />

• Out-Licensed <strong>Product</strong>s/Combination Treatment Modalities<br />

• <strong>Oryzon</strong> <strong>Genomics</strong> S.A. - <strong>Pipeline</strong> <strong>Product</strong>s Glance<br />

Get complete TOC here @ http://www.bigmarketresearch.com/oryzon-genomics-saproduct-pipeline-review-<strong>2014</strong>-market


FOR MORE DETAILS<br />

Visit us at :<br />

http://www.bigmarketresearch.com/oryzon-genomics-saproduct-pipeline-review-<strong>2014</strong>-market<br />

Stay With Us:<br />

TELEPHONE: +1 (855) 711-1555<br />

E-MAIL: sales@bigmarketresearch.com<br />

5933 NE Win Sivers Drive,<br />

#205, Portland, OR 97220<br />

United States

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!